Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of hyperglycemia and its impact on mortality among HIV patients in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targets

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of recent HIV infection in Georgia, 2018-2020

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIV

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A series of cases of HIV and acute Hepatitis B coinfection – treatment issues

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Progress in roll-out of generic dolutegravir-based treatment in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Avidity of antibodies to Hepatitis C virus in persons with newly diagnosed HCV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Latvia on its’ way to achieve WHO plan to eliminate Hepatitis C by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Co-infections with Hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Occult HBV infection and two clinical cases with malignant comorbidities

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Randomized control trial of home-based Hepatitis C self-testing in key populations in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patient

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Differentiated Service Delivery for HIV and Beyond - Anna Grimsrud

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Upscaling Laboratory Services to Achieve the 95-95-95 - Pascale Ondoa

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Achieving 95-95-95: Implications for Asia and the Pacific Region - Eamonn Murphy

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region